Page last updated: 2024-12-07
4-hydroperoxydechlorocyclophosphamide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
4-hydroperoxydechlorocyclophosphamide: preactivated analog of cyclophosphamide that undergoes an elimination reaction to yield acrolein & dechlorophosphoramide mustard; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 127131 |
| MeSH ID | M0175425 |
Synonyms (10)
| Synonym |
|---|
| 76353-74-7 |
| 4-hydroperoxydechlorocyclophosphamide |
| diethyl-4'-hydroperoxycyclophosphamide |
| hydroperoxide, 2-(diethylamino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl, p-oxide |
| 2-(diethylamino)tetrahydro-2h-1,3,2-oxazaphosphorin-4-yl hydroperoxide p-oxide |
| 2h-1,3,2-oxazaphosphorinan-4-yl hydroperoxide, 2-(diethylamino)-, 2-oxide |
| asta 7037 |
| 2-(diethylamino)-4-hydroperoxy-1,3,2lambda~5~-oxazaphosphinan-2-one |
| DTXSID20997746 |
| n,n-diethyl-4-hydroperoxy-2-oxo-1,3,2lambda5-oxazaphosphinan-2-amine |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.53
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.53) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||